| Genzyme Belgium | Genzyme Corporate | Search | Contact us | |||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Signs, Symptoms & Clinical presentation MPS I is a heterogeneous disease spanning a spectrum of severity. Individuals with the most severe form of MPS I typically suffer from a number of progressively debilitating symptoms, including mental retardation. Their maximum lifespan is approximately 8 to 10 years[1]. Individuals at the opposite end of the disease spectrum have physical symptoms that can be as severe, but they generally retain normal intellect and stature, and may have a normal lifespan. Because the disease generally affects many organ systems and can present in a variety of ways, diagnosis and treatment of MPS I disease may require collaboration and communication among geneticists, neurologists, pediatricians, developmental specialists, surgeons, cardiologists, gastroenterologists, physiotherapists, and primary care providers. General physical appearance
The physical appearance for MPS I is quite variable:
Specific manifestations References 1. Neufeld, E.F., and Muenzer, J. (1995) The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds.). 7th edition. McGraw-Hill, Medical Publishing Division, pp. 2465. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Terms and Conditions of Use | Privacy Policy | © 2010 Genzyme Corporation. All rights reserved. | ![]() |
|